Dec 3 (Reuters) – An experimental cancer therapy being
developed by Novartis AG eliminated an aggressive form
of blood cancer in 82 percent of children and young adults
treated with modified immune…
The post CORRECTED-Novartis says 82 pct of leukemia patients in remission after CAR-T appeared first on NASDAQ.